Author:
Xie Chengxin,Wang Chenglong,Luo Hua
Abstract
Abstract
Background
Both osteoporosis and cognitive impairment affect overall health in elderly individuals. This study aimed to investigate the association between cognitive impairment and the risk of osteoporosis.
Methods
PubMed, Web of Science, and the Cochrane Library were searched for studies on the association between osteoporosis and cognitive impairment from their inception until August 2023. The random-effects model was used to calculate the pooled risk ratio (RR) of osteoporosis in patients with cognitive impairment. Subgroup analysis was used to detect the sources of heterogeneity. Sensitivity analysis was used to test the robustness of the pooled results. Funnel plots, Egger’s test, and Begg’s test were used to test publication bias.
Results
Ten studies involving 9,872 patients were included in this meta-analysis. The pooled results showed that patients with cognitive impairment had an increased risk of osteoporosis (RR = 1.56, 95% confidence interval [CI]: 1.30–1.87, p < 0.001). Subgroup analysis showed that patients with Alzheimer’s disease (AD) are at 1.7-fold risk of osteoporosis compared with the control group (RR = 1.70, 95% CI: 1.23–2.37, p = 0.001), and sex, cognitive classification, study region, study design, and study quality might be the sources of heterogeneity. Sensitivity analysis showed robustness of the pooled results. No significant publication bias was found (Begg’s test, p = 0.474; Egger’s test, p = 0.065).
Conclusion
Current evidence suggests that patients with cognitive impairment are at increased risk of osteoporosis, especially patients with AD.
Funder
Enze Medical Center (Group) Scientific Research
Publisher
Springer Science and Business Media LLC
Subject
Geriatrics and Gerontology
Reference46 articles.
1. Compston JE, McClung MR, Leslie WD. Osteoporos Lancet. 2019;393(10169):364–76.
2. Scaturro D, Leone G, Mauro GL. Bone mineral density, fragility fractures and clinical risk factors. EuroMediterranean Biomed J. 2018;13:155–9.
3. Yu F, Xia W. The epidemiology of osteoporosis, associated fragility fractures, and management gap in China. Arch Osteoporos. 2019;14(1).
4. Wang L, Yu W, Yin X, Cui L, Tang S, Jiang N, et al. Prevalence of osteoporosis and fracture in China: the China osteoporosis prevalence study. JAMA Netw open. 2021;4(8):e2121106.
5. Zhang Y, Chen CY, Liu YW, Rao SS, Tan YJ, Qian YX, et al. Neuronal induction of bone-fat imbalance through Osteocyte Neuropeptide Y. Adv Sci (Weinh). 2021;8(24):e2100808.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献